Several fundamental mechanisms that contribute to tumor resistance have been identified, such as activation of the mitogen-activated protein kinase (MAPK) signaling pathway and impaired T cell response caused by diminished tumor antigen expression[17]. This evidence concerns the gene WNK2 and neoplasm.